Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease.
about
Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditionsImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisVascular, glial, and lymphatic immune gateways of the central nervous systemLive Imaging of Immune Responses in Experimental Models of Multiple SclerosisTwo-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sitesNicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system.2-photon imaging of phagocyte-mediated T cell activation in the CNS.Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structuresMechanism of action of oral fingolimod (FTY720) in multiple sclerosis.Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator.The immune response in glaucoma: a perspective on the roles of oxidative stressMapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAECCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progressionCumulative autoimmunity: T cell clones recognizing several self-epitopes exhibit enhanced pathogenicityHighly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.Inflammation on the mind: visualizing immunity in the central nervous system.A Novel Cervical Spinal Cord Window Preparation Allows for Two-Photon Imaging of T-Cell Interactions with the Cervical Spinal Cord Microvasculature during Experimental Autoimmune Encephalomyelitis.Cell-autonomous and environmental contributions to the interstitial migration of T cells.Fragile privileges: autoimmunity in brain and eyeAn autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS.Peripheral tolerance and autoimmunity: lessons from in vivo imaging.Functional immunoimaging: the revolution continues.Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid.Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?Knowledge and practices of healthcare workers in relation to bloodborne pathogens in a tertiary care hospital, Western Saudi Arabia.Automatic detection of motion blur in intravital video microscopy image sequences via directional statistics of log-Gabor energy maps.
P2860
Q21342825-8FCFEC0A-2C15-44A5-8A76-74B775A08C76Q26744629-8980DA93-083E-4B4B-9EF2-1CFC91141D98Q28071461-39EA350E-7970-4E53-AB31-0653C112A9B9Q28075478-5C5A1938-3CD4-457F-8BBD-1248F00EA323Q30492842-26795103-971A-4C68-93B9-B0DEA0A4A6FFQ30495158-2724B20C-61EB-4566-B79C-D8C4C00B3CE4Q30536629-74B3DD1A-E2A8-4A6A-B876-06430B9FD138Q31044261-4246D2CC-A2D3-447E-818D-3A6A61ED9161Q33630513-DC725DFB-0678-4006-A564-07AAB1860E25Q33810559-2AA4E98F-89D4-45F4-BC78-05557A9A6339Q34345420-616A8BDD-8DCC-4E65-AE42-A4753413AC87Q34388254-60EA02F1-E613-42E4-B53E-CAE337DEDA0AQ34602629-DDD0BC8A-27D0-4EA9-A8C6-FF8257FD8F17Q35185219-1B809CB1-AF8C-49C9-B75C-414FA5EE3EF1Q35928352-D039EAFE-E2E1-42F0-BF39-A5D81EDD078BQ36303835-F0EB3EC6-95B5-4B44-8DC9-F92DAD18639DQ36742838-5A5F1830-E9A3-4251-9FCB-CD1B40E7519DQ37184161-D3ECF3F6-99AF-4F2B-8915-E4CBD1EC77EDQ37747214-0183F845-0C10-4578-B53A-BAA007D6ECD3Q37771878-C689CDFE-2B2A-42B9-BFE5-4A64CA3BB64EQ37785483-1A619E2E-1F5B-423F-BA3B-1590EE9B2CADQ38020962-780FBA0E-B81A-4D28-94A3-289DCD71AC40Q38041511-71369395-8547-427B-AF6F-773DB04EC055Q38061859-4785CE45-25B3-4B94-BB12-0162E8479E13Q40008069-31A831E9-C238-4E91-B8DB-B7DA62A9BC41Q41528091-AFD3D660-FB1D-41C8-89AC-59695D8AF089Q42237826-3231117A-0AF4-4B27-B28E-E9C708295D57Q51016949-3DDB312F-80B5-42E4-B076-52F175CD51A0
P2860
Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Blood-borne soluble protein an ...... exacerbates clinical disease.
@ast
Blood-borne soluble protein an ...... exacerbates clinical disease.
@en
type
label
Blood-borne soluble protein an ...... exacerbates clinical disease.
@ast
Blood-borne soluble protein an ...... exacerbates clinical disease.
@en
prefLabel
Blood-borne soluble protein an ...... exacerbates clinical disease.
@ast
Blood-borne soluble protein an ...... exacerbates clinical disease.
@en
P2093
P2860
P356
P1476
Blood-borne soluble protein an ...... exacerbates clinical disease.
@en
P2093
P2860
P304
18625-18630
P356
10.1073/PNAS.0705033104
P407
P577
2007-11-13T00:00:00Z